PHLI Insider Trading Activity and SEC Form 4 Filings
PHLI insider trading summary
No open-market insider purchases or sales of Pacifichealth Laboratories Inc (PHLI) have been reported on SEC Form 4 in the past 12 months.
Latest PHLI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 11, 2011 | Robert Portman | Director | Buy | $100K (400,000 @ $0.25) |
| May 11, 2011 | Frederick G Duffner | President and CEO | Buy | $25K (100,000 @ $0.25) |
| May 11, 2011 | Michael E Cahr | Director | Buy | $50K (200,000 @ $0.25) |
| May 11, 2011 | Lee Feldman | Director | Buy | $50K (200,000 @ $0.25) |
| Mar 22, 2011 | Frederick G Duffner | President and CEO | Buy | $25K (100,000 @ $0.25) |
| Mar 22, 2011 | Robert Portman | Director | Buy | $95K (380,000 @ $0.25) |
| Sep 8, 2009 | Adam Mizel | Director | Buy | $1K (5,000 @ $0.25) |
| Sep 4, 2009 | Adam Mizel | Director | Buy | $1K (5,000 @ $0.24) |
| Aug 20, 2009 | Robert Portman | Director | Sell | $16K (50,000 @ $0.32) |
| Aug 19, 2009 | Stephen P Kuchen | CFO | Buy | $2K (5,000 @ $0.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.